Showing results (261-270 of 396) with videos related to

Sort By:
Pageof 40
Leukemia|May 10, 2000
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AMLS Schnittger, U Kinkelin, C Schoch, et al.
Annals of Hematology|July 1, 1991
Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II studyW Hiddemann, R Rottmann, B Wörmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinomaA Harstrick, C H Köhne, W Hiddemann, et al.
Klinische Padiatrie|July 1, 1989
[Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years]S Bielack, J Beck, G Delling, et al.
Leukemia|February 1, 1994
Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factorC Reuter, U Auf der Landwehr, E Schleyer, et al.
Seminars in Oncology|October 1, 1993
Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study GroupW Hiddemann, M Unterhalt, C Pott, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)]T Liersch, W Gatzemeier, P Scharnberg, et al.
Leukemia|December 1, 1992
Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cellsW Hiddemann, E Schleyer, M Unterhalt, et al.
Cancer|July 15, 1986
DNA stemline heterogeneity in colorectal cancerW Hiddemann, D B Von Bassewitz, H J Kleinemeier, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Frequency and clinical significance of DNA aneuploidy in acute leukemiaW Hiddemann, B Wörmann, J Ritter, et al.
Pageof 40